Ophthalmology Drugs and Devices Market June 2021 Report On 2021 SWOT Analysis, Key Business Strategies, Leading Industry Players, Regional Growth, Demand, Share, Challenges, Opportunities and 2030 Forecast Research Report

In a recent published report, Kenneth Research has updated the market report for Ophthalmology Drugs and Devices Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4  billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Ophthalmology Drugs and Devices Market products.

Download Sample of This Strategic Report: 
https://www.kennethresearch.com/sample-request-10233555

Moreover, the median health expenditure per capita recorded in the high-income, upper-middle income, and low & lower-middle income countries, recorded to be over USD 2,000, USD 400, and USD 100 respectively. Additionally, in the same year, the spending on health in high-income countries and in the low- and middle-income countries comprised approximately 8.2% and 6.3% of the GDP respectively.

The global ophthalmology drugs market is expected to grow impressively by 2028. The market is driven by various factors which include increase prevalence of eye related disorders such as glaucoma and cataract aging population, regulatory approvals to new drugs and devices, new technologies such as minimally invasive surgical devices, focus on combining drugs and device therapies and increasing economic factors such as rise in disposable income and health expenditure. The market opportunities lie in the growing awareness especially in the emerging and underdeveloped countries, demand for intraocular lenses, phacoemulsification devices and other devices and therapies. However, factors such as expiration of patents, drying pipelines and major slowdowns in economies may hamper the market growth.

“Final Report will add the analysis of the impact of COVID-19 on this industry.”

The market is segmented on the basis of ophthalmic diagnostic & monitoring equipment market which includes optical coherence tomography scanners market, ultra sound imaging systems, fundus camera market, ophthalmoscopes, retinoscope and other market. The surgical devices include cataract surgery device, intraocular lens market, phacoemulsification devices, glaucoma surgery device market and others. The popular drugs include Lucentis, Eylea, Avastin, Restasis, Lumigan and Ganfort, Xalatan/Xalacom, Pataday and other. The drugs include drugs for glaucoma, retinal disorder, dry eye, allergic conjunctivitis, inflammation and conjunctivitis. The end users include hospitals, eye clinics, diagnostic centres and patients.

The major geographies include North America, Europe, Asia-Pacific and rest of the world. North America is the largest market followed by Europe and Asia pacific. The North American market is driven high awareness, availability of drugs and devices, better regulatory outreach which leads to increased trust in the devices and drugs. Asia Pacific market to have high growth rate driven by strong markets in China and India. Market includes top players such as Abbot Laboratories, Alcon Inc, Ellex Medical lasers ltd, Essilor international S.A., Allergan Inc, Bausch & Lomb Inc, Carl Zeiss Meditec AG, Johnson and Johnson and Hoya Corporation.

Download Sample of This Strategic Report: 
https://www.kennethresearch.com/sample-request-10233555

Company Profile Include:

1. Abbot Laboratories
2. Alcon Inc
3. Ellex Medical lasers ltd
4. Essilor international S.A.
5. Allergan Inc
6. Bausch & Lomb Inc
7. Carl Zeiss Meditec AG
8. Johnson and Johnson
9. Hoya corporation
10. Pfizer Inc
11. Roche holding AG
12. Santen pharmaceutical co. ltd
13. Staar surgical company
14. Iridex corporation
15. Merc & Co. Inc
16. Nidek Co. Ltd
17. Topcon corporation
18. Novagali Pharma S.A.
19. Novartis AG
20. Nicox
21. Acucela
22. Senju
23. Bayer
24. Valeant
25. Regeneron
26. Akorn
27. Eyemed
28. Visioncare ophthalmic technologies
29. Biotech Visioncare
30. VSP

This Research Report covers

1. Historical data
2. Revenue forecasts, growth rates and CAGR up to 2028
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data

Request for Complete Report:
https://www.kennethresearch.com/sample-request-10233555

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research

Email: Sales@kennethresearch.com

Phone: +1 313 462 0609

James Bullock is a Research Expert with a demonstrated history of working in the professional training & coaching industry. Strong professional skilled in business strategy , Strategic Planning, Research Strategy, and Marketing. also have interest in new innovations and technology

Leave a Reply